|
20.1.2022 |
DA |
Den Europæiske Unions Tidende |
C 29/7 |
Lægemidler — Liste over markedsføringstilladelser udstedt af EØS-EFTA-staterne i første halvdel af 2021
(2022/C 29/04)
underudvalg i for frie varebevægelser
Til Det Blandede EØS-Udvalgs underretning
Under henvisning til afgørelse truffet af Det Blandede EØS-Udvalg nr. 74/1999 af 28. maj 1999 opfordres Det Blandede EØS-Udvalg til på sit møde den 24. september 2021 at notere sig følgende lister over markedsføringstilladelser for lægemidler udstedt i perioden 1. januar-30. juni 2021:
|
Bilag I |
Liste over nye markedsføringstilladelser |
|
Bilag II |
Liste over fornyede markedsføringstilladelser |
|
Bilag III |
Liste over udvidede markedsføringstilladelser |
|
Bilag IV |
Liste over tilbagetrukne markedsføringstilladelser |
|
Bilag V |
Liste over suspenderede markedsføringstilladelser |
BILAG I
Liste over nye markedsføringstilladelser
Følgende markedsføringstilladelser er blevet udstedt i EØS-EFTA-staterne i perioden 1. januar-30. juni 2021:
|
EU-Nummer |
Produkt |
Land |
Udstedelsesdato |
|
EU/1/20/1515 |
Abevmy |
Island |
12.5.2021 |
|
EU/1/20/1515 |
Abevmy |
Liechtenstein |
30.4.2021 |
|
EU/1/20/1515 |
Abevmy |
Norge |
28.4.2021 |
|
EU/1/20/1512 |
Abirateron Accord |
Liechtenstein |
30.4.2021 |
|
EU/1/20/1512 |
Abiraterone Accord |
Island |
14.5.2021 |
|
EU/1/20/1512 |
Abiraterone Accord |
Norge |
6.5.2021 |
|
EU/1/21/1553 |
Abiraterone Krka |
Liechtenstein |
30.6.2021 |
|
EU/1/21/1553 |
Abiraterone Krka |
Norge |
30.6.2021 |
|
EU/1/20/1476 |
Adakveo (særlige vilkår) |
Liechtenstein |
15.1.2021 |
|
EU/1/21/1554 |
Adtralza |
Liechtenstein |
30.6.2021 |
|
EU/1/21/1554 |
Adtralza |
Norge |
22.6.2021 |
|
EU/1/20/1509 |
Alymsys |
Island |
14.4.2021 |
|
EU/1/20/1509 |
Alymsys |
Liechtenstein |
30.4.2021 |
|
EU/1/20/1509 |
Alymsys |
Norge |
8.4.2021 |
|
EU/1/20/1469 |
Arikayce liposomal |
Liechtenstein |
15.1.2021 |
|
EU/1/20/1475 |
Arsenic trioxide medac |
Liechtenstein |
28.2.2021 |
|
EU/2/18/228 |
Arti-Cell Forte |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1473 |
Ayvakyt |
Liechtenstein |
28.2.2021 |
|
EU/1/18/1339 |
Bevespi Aerosphere |
Liechtenstein |
28.2.2021 |
|
EU/2/99/017 |
Bovalto Ibraxion |
Liechtenstein |
28.2.2021 |
|
EU/1/21/1534 |
BroPair Spiromax |
Island |
14.4.2021 |
|
EU/1/21/1534 |
BroPair Spiromax |
Liechtenstein |
30.4.2021 |
|
EU/1/21/1534 |
BroPair Spiromax |
Norge |
8.4.2021 |
|
EU/2/10/112 |
BTVPUR AlSap 1 |
Liechtenstein |
28.2.2021 |
|
EU/2/09/094 |
BTVPUR AlSap 8 |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1505 |
Byfavo |
Island |
26.4.2021 |
|
EU/1/20/1505 |
Byfavo |
Norge |
8.4.2021 |
|
EU/1/20/1505 |
Byvafo |
Liechtenstein |
30.4.2021 |
|
EU/120/1448 |
Cabazitaxel Accord |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1479 |
Calquence |
Liechtenstein |
15.1.2021 |
|
EU/1/21/1560 |
Celsunax |
Liechtenstein |
30.6.2021 |
|
EU/1/21/1560 |
Celsunax |
Norge |
23.6.2021 |
|
EU/2/20/264 |
CircoMax Myco |
Island |
4.1.2021 |
|
EU/2/20/264 |
CircoMax Myco |
Liechtenstein |
15.1.2021 |
|
EU/1/19/1395 |
Clopidogrel/Acetylsalicylic acid Mylan |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1528 |
Comirnaty (særlige vilkår) |
Liechtenstein |
15.1.2021 |
|
EU/1/21/1542 |
Copiktra |
Island |
9.6.2021 |
|
EU/1/21/1542 |
Copiktra |
Liechtenstein |
30.6.2021 |
|
EU/1/21/1542 |
Copiktra |
Norge |
3.6.2021 |
|
EU/2/18/230 |
Cortacare |
Liechtenstein |
28.2.2021 |
|
EU/1/21/1529 |
COVID-19 Vaccine AstraZeneca |
Island |
29.1.2021 |
|
EU/1/21/1529 |
COVID-19 Vaccine AstraZeneca |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1529 |
COVID-19 Vaccine AstraZeneca (Vaxzevria) |
Norge |
29.1.2021 |
|
EU/1/20/1525 |
COVID-19 Vaccine Janssen |
Island |
11.3.2021 |
|
EU/1/20/1525 |
COVID-19 Vaccine Janssen |
Liechtenstein |
30.4.2021 |
|
EU/1/20/1525 |
COVID-19 Vaccine Janssen |
Norge |
11.3.2021 |
|
EU/1/20/1507 |
COVID-19 Vaccine Moderna |
Island |
6.1.2021 |
|
EU/1/20/1507 |
COVID-19 Vaccine Moderna (særlige vilkår) |
Liechtenstein |
15.1.2021 |
|
EU/1/20/1507 |
COVID-19 Vaccine Moderna (Spikevax) |
Norge |
6.1.2021 |
|
EU/2/21/271 |
Credelio Plus |
Island |
26.4.2021 |
|
EU/2/21/271 |
Credelio Plus |
Liechtenstein |
30.4.2021 |
|
EU/2/21/271 |
Credelio Plus |
Norge |
19.4.2021 |
|
EU/1/17/1248 |
Darunavir Krka d.d. |
Liechtenstein |
28.2.2021 |
|
EU/2/21/270 |
Daxocox |
Island |
14.5.2021 |
|
EU/2/21/270 |
Daxocox |
Liechtenstein |
30.4.2021 |
|
EU/2/21/270 |
Daxocox |
Norge |
3.6.2021 |
|
EU/1/19/1412 |
Deferasirox Accord |
Liechtenstein |
28.2.2021 |
|
EU/1/21/1547 |
Drovelis |
Island |
8.6.2021 |
|
EU/1/21/1547 |
Drovelis |
Liechtenstein |
30.6.2021 |
|
EU/1/21/1547 |
Drovelis |
Norge |
3.6.2021 |
|
EU/1/18/1284 |
Dzuveo |
Liechtenstein |
28.2.2021 |
|
EU/1/21/1549 |
Efmody |
Island |
10.6.2021 |
|
EU/1/21/1549 |
Efmody |
Liechtenstein |
30.4.2021 |
|
EU/1/21/1549 |
Efmody |
Norge |
10.6.2021 |
|
EU/1/20/1504 |
Elzonris |
Island |
19.1.2021 |
|
EU/1/20/1504 |
Elzonris |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1504 |
Elzonris |
Norge |
18.1.2021 |
|
EU/1/18/1330 |
Emgality |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1438 |
Enerzair Breezhaler |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1508 |
Enhertu |
Island |
28.1.2021 |
|
EU/1/20/1508 |
Enhertu |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1508 |
Enhertu |
Norge |
26.1.2021 |
|
EU/1/21/1559 |
Enspryng |
Liechtenstein |
30.6.2021 |
|
EU/2/20/268 |
Enteroporc Coli |
Island |
21.1.2021 |
|
EU/2/20/268 |
Enteroporc Coli |
Liechtenstein |
15.1.2021 |
|
EU/2/20/268 |
Enteroporc Coli |
Norge |
3.6.2021 |
|
EU/2/20/262 |
Enteroporc Coli AC |
Island |
8.1.2021 |
|
EU/2/20/262 |
Enteroporc Coli AC |
Liechtenstein |
15.1.2021 |
|
EU/1/20/1472 |
Equidacent |
Liechtenstein |
15.1.2021 |
|
EU/1/19/1392 |
Ervebo |
Liechtenstein |
28.2.2021 |
|
EU/1/12/750 |
Esmya |
Island |
1.2.2021 |
|
EU/1/21/1551 |
Evkeeza |
Liechtenstein |
30.6.2021 |
|
EU/1/21/1551 |
Evkeeza |
Norge |
30.6.2021 |
|
EU/1/21/1531 |
Evrysdi |
Island |
14.4.2021 |
|
EU/1/21/1531 |
Evrysdi |
Liechtenstein |
30.4.2021 |
|
EU/1/21/1531 |
Evrysdi |
Norge |
8.4.2021 |
|
EU/1/20/1489 |
Exparel liposomal |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1477 |
Fampridine Accord |
Liechtenstein |
15.1.2021 |
|
EU/1/20/1491 |
Fintepla |
Island |
22.1.2021 |
|
EU/1/20/1491 |
Fintepla |
Liechtenstein |
15.1.2021 |
|
EU/1/20/1491 |
Fintepla |
Norge |
15.1.2021 |
|
EU/1/18/1326 |
Flucelvax Tetra |
Liechtenstein |
28.2.2021 |
|
EU/1/19/1375 |
Grasustek |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1503 |
Heplisav B |
Island |
22.2.2021 |
|
EU/1/20/1503 |
Heplisav B |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1503 |
Heplisav B |
Norge |
25.2.2021 |
|
EU/2/20/258 |
Increxxa |
Liechtenstein |
28.2.2021 |
|
EU/2/20/258 |
Increxxa |
Norge |
22.2.2021 |
|
EU/2/17/208 |
Ingelvac PCV FLEX |
Liechtenstein |
28.2.2021 |
|
EU/2/17/213 |
Innovax-ND-IBD |
Liechtenstein |
28.2.2021 |
|
EU/2/20/256 |
Innovax-ND-ILT |
Liechtenstein |
15.1.2021 |
|
EU/2/20/256 |
Innovax-ND-ILT |
Norge |
4.1.2021 |
|
EU/1/20/1514 |
Inrebic |
Island |
19.2.2021 |
|
EU/1/20/1514 |
Inrebic |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1514 |
Inrebic |
Norge |
11.2.2021 |
|
EU/2/18/232 |
Isemid |
Liechtenstein |
28.2.2021 |
|
EU/1/19/1396 |
Ivozall |
Liechtenstein |
28.2.2021 |
|
EU/1/21/1557 |
Jayempi |
Liechtenstein |
30.6.2021 |
|
EU/1/21/1557 |
Jayempi |
Norge |
30.6.2021 |
|
EU/1/21/1538 |
Jemperli |
Island |
12.5.2021 |
|
EU/1/21/1538 |
Jemperli |
Liechtenstein |
30.4.2021 |
|
EU/1/21/1538 |
Jemperli |
Norge |
28.4.2021 |
|
EU/1/20/1480 |
Jyseleca |
Liechtenstein |
15.1.2021 |
|
EU/1/21/1532 |
Kesimpta |
Island |
15.4.2021 |
|
EU/1/21/1532 |
Kesimpta |
Liechtenstein |
30.4.2021 |
|
EU/1/21/1532 |
Kesimpta |
Norge |
8.4.2021 |
|
EU/1/20/1506 |
Kixelle |
Island |
18.2.2021 |
|
EU/1/20/1506 |
Kixelle |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1506 |
Kixelle |
Norge |
11.2.2021 |
|
EU/1/21/1552 |
Koselugo |
Liechtenstein |
30.6.2021 |
|
EU/1/21/1552 |
Koselugo |
Norge |
22.6.2021 |
|
EU/1/20/1520 |
Lenalidomide Krka |
Island |
4.3.2021 |
|
EU/1/20/1520 |
Lenalidomide Krka |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1520 |
Lenalidomide Krka |
Norge |
21.6.2021 |
|
EU/1/20/1521 |
Lenalidomide Krka d.d. |
Island |
5.3.2021 |
|
EU/1/20/1521 |
Lenalidomide Krka d.d. |
Liechtenstein |
30.4.2021 |
|
EU/1/20/1521 |
Lenalidomide Krka d.d. |
Norge |
16.6.2021 |
|
EU/1/20/1519 |
Lenalidomide Krka d.d. Novo mesto |
Island |
24.2.2021 |
|
EU/1/20/1519 |
Lenalidomide Krka d.d. Novo mesto |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1519 |
Lenalidomide Krka d.d. Novo mesto |
Norge |
18.6.2021 |
|
EU/1/20/1490 |
Lenalidomide Mylan |
Island |
11.1.2021 |
|
EU/1/20/1490 |
Lenalidomide Mylan |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1494 |
Leqvio |
Island |
5.1.2021 |
|
EU/1/20/1494 |
Leqvio |
Liechtenstein |
15.1.2021 |
|
EU/1/20/1516 |
Lextemy |
Island |
12.5.2021 |
|
EU/1/20/1516 |
Lextemy |
Liechtenstein |
30.4.2021 |
|
EU/1/20/1516 |
Lextemy |
Norge |
28.4.2021 |
|
EU/1/20/1493 |
Libmeldy |
Island |
14.1.2021 |
|
EU/1/20/1493 |
Libmeldy |
Liechtenstein |
15.1.2021 |
|
EU/1/20/1493 |
Libmeldy |
Norge |
8.1.2021 |
|
EU/2/20/261 |
Librela |
Liechtenstein |
15.1.2021 |
|
EU/2/20/261 |
Librela |
Norge |
4.1.2021 |
|
EU/1/20/1470 |
Lumeblue |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1522 |
Lumoxiti |
Island |
19.2.2021 |
|
EU/1/20/1522 |
Lumoxiti |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1522 |
Lumoxiti |
Norge |
11.2.2021 |
|
EU/1/21/1548 |
Lydisilka |
Island |
8.6.2021 |
|
EU/1/21/1548 |
Lydisilka |
Liechtenstein |
30.6.2021 |
|
EU/1/21/1548 |
Lydisilka |
Norge |
31.5.2021 |
|
EU/1/20/1483 |
MenQuadfi |
Liechtenstein |
15.1.2021 |
|
EU/2/20/259 |
Mhyosphere PCV ID |
Liechtenstein |
28.2.2021 |
|
EU/2/20/259 |
Mhyosphere PCV ID |
Norge |
4.1.2021 |
|
EU/1/20/1445 |
Mvabea |
Liechtenstein |
28.2.2021 |
|
EU/1/18/1325 |
Namuscla |
Liechtenstein |
28.2.2021 |
|
EU/2/20/267 |
NexGard Combo |
Island |
25.1.2021 |
|
EU/2/20/267 |
NexGard Combo |
Liechtenstein |
28.2.2021 |
|
EU/2/20/267 |
NexGard Combo |
Norge |
20.1.2021 |
|
EU/1/21/1537 |
Nexpovio |
Island |
30.3.2021 |
|
EU/1/21/1537 |
Nexpovio |
Liechtenstein |
30.4.2021 |
|
EU/1/21/1537 |
Nexpovio |
Norge |
8.4.2021 |
|
EU/1/18/1290 |
Nityr |
Liechtenstein |
28.2.2021 |
|
EU/2/20/265 |
Nobivac DP Plus |
Island |
4.1.2021 |
|
EU/2/20/265 |
Nobivac DP Plus |
Liechtenstein |
15.1.2021 |
|
EU/1/19/1364 |
Nuceiva |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1486 |
Nyvepria |
Liechtenstein |
15.1.2021 |
|
EU/1/20/1485 |
Obiltoxaximab SFL (under særlige omstændigheder) |
Liechtenstein |
15.1.2021 |
|
EU/1/20/1523 |
Ogluo |
Island |
22.2.2021 |
|
EU/1/20/1523 |
Ogluo |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1523 |
Ogluo |
Norge |
23.2.2021 |
|
EU/1/20/1499 |
Onbevzi |
Island |
19.1.2021 |
|
EU/1/20/1499 |
Onbevzi |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1499 |
Onbevzi |
Norge |
15.1.2021 |
|
EU/1/21/1530 |
Ontozry |
Island |
15.4.2021 |
|
EU/1/21/1530 |
Ontozry |
Liechtenstein |
30.4.2021 |
|
EU/1/21/1530 |
Ontozry |
Norge |
9.4.2021 |
|
EU/1/21/1556 |
Onureg |
Liechtenstein |
30.6.2021 |
|
EU/1/21/1556 |
Onureg |
Norge |
22.6.2021 |
|
EU/1/21/1544 |
Orladeyo |
Island |
14.5.2021 |
|
EU/1/21/1544 |
Orladeyo |
Liechtenstein |
30.6.2021 |
|
EU/1/21/1544 |
Orladeyo |
Norge |
6.5.2021 |
|
EU2/20/260 |
OvuGel |
Liechtenstein |
28.2.2021 |
|
EU/2/20/260 |
OvuGel |
Norge |
4.1.2021 |
|
EU/1/20/1496 |
Oxlumo |
Liechtenstein |
15.1.2021 |
|
EU/1/20/1510 |
Oyavas |
Island |
14.4.2021 |
|
EU/1/20/1510 |
Oyavas |
Liechtenstein |
30.4.2021 |
|
EU/1/20/1510 |
Oyavas |
Norge |
8.4.2021 |
|
EU/1/20/1495 |
Palforzia |
Island |
18.1.2021 |
|
EU/1/20/1495 |
Palforzia |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1495 |
Palforzia |
Norge |
15.1.2021 |
|
EU/1/21/1535 |
Pemazyre |
Island |
30.3.2021 |
|
EU/1/21/1535 |
Pemazyre |
Liechtenstein |
30.4.2021 |
|
EU/1/21/1535 |
Pemazyre |
Norge |
8.4.2021 |
|
EU/1/20/1487 |
Phelinun |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1497 |
Phesgo |
Island |
11.1.2021 |
|
EU/1/20/1497 |
Phesgo |
Liechtenstein |
15.1.2021 |
|
EU/1/21/1550 |
Ponvory |
Island |
9.6.2021 |
|
EU/1/21/1550 |
Ponvory |
Liechtenstein |
30.6.2021 |
|
EU/1/21/1550 |
Ponvory |
Norge |
4.6.2021 |
|
EU/2/20/254 |
Prevexxion RN |
Liechtenstein |
28.2.2021 |
|
EU/2/20/255 |
Prevexxion RN+HVT+IBD |
Norge |
4.1.2021 |
|
EU/2/17/211 |
Prevomax |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1482 |
Rekambys |
Island |
11.1.2021 |
|
EU/1/20/1482 |
Rekambys |
Liechtenstein |
15.1.2021 |
|
EU/1/20/1482 |
Rekambys |
Norge |
5.1.2021 |
|
EU/1/20/1527 |
Retsevmo |
Island |
19.2.2021 |
|
EU/1/20/1527 |
Retsevmo |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1527 |
Retsevmo |
Norge |
11.2.2021 |
|
EU/2/20/263 |
Rexxolide |
Island |
4.1.2021 |
|
EU/2/20/263 |
Rexxolide |
Liechtenstein |
28.2.2021 |
|
EU/1/19/1400 |
Rhokiinsa |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1488 |
Rivaroxaban Accord |
Liechtenstein |
15.1.2021 |
|
EU/1/20/1502 |
Roclanda |
Island |
12.1.2021 |
|
EU/1/20/1502 |
Roclanda |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1502 |
Roclanda |
Norge |
14.1.2021 |
|
EU/1/20/1460 |
Rozlytrek |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1518 |
Rukobia |
Island |
19.2.2021 |
|
EU/1/20/1518 |
Rukobia |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1518 |
Rukobia |
Norge |
11.2.2021 |
|
EU/1/20/1431 |
Ruxience |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1435 |
Sarclisa |
Liechtenstein |
28.2.2021 |
|
EU/1/21/1533 |
Seffalair Spiromax |
Island |
14.4.2021 |
|
EU/1/21/1533 |
Seffalair Spiromax |
Liechtenstein |
30.4.2021 |
|
EU/1/21/1533 |
Seffalair Spiromax |
Norge |
8.4.2021 |
|
EU/1/20/1517 |
Sibnayal |
Island |
14.5.2021 |
|
EU/1/20/1517 |
Sibnayal |
Liechtenstein |
30.6.2021 |
|
EU/1/20/1517 |
Sibnayal |
Norge |
5.5.2021 |
|
EU/1/20/1501 |
Sogroya |
Island |
15.4.2021 |
|
EU/1/20/1501 |
Sogroya |
Liechtenstein |
30.4.2021 |
|
EU/1/20/1501 |
Sogroya |
Norge |
8.4.2021 |
|
EU/2/20/269 |
Solensia |
Liechtenstein |
28.2.2021 |
|
EU/2/20/269 |
Solensia |
Norge |
14.6.2021 |
|
EU/1/19/1421 |
Staquis |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1511 |
Sunitinib Accord |
Island |
4.3.2021 |
|
EU/1/20/1511 |
Sunitinib Accord |
Liechtenstein |
30.4.2021 |
|
EU/1/20/1511 |
Sunitinib Accord |
Norge |
5.3.2021 |
|
EU/1/20/1484 |
Supemtek |
Liechtenstein |
15.1.2021 |
|
EU2/09/099 |
Suvaxyn PCV |
Liechtenstein |
28.2.2021 |
|
EU/2/18/231 |
Syvazul BTV |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1492 |
Tecartus |
Island |
8.1.2021 |
|
EU/1/20/1492 |
Tecartus (særlige vilkår) |
Liechtenstein |
15.1.2021 |
|
EU/1/19/1378 |
Temybric Ellipta |
Liechtenstein |
28.2.2021 |
|
EU/1/21/1536 |
Thiotepa Riemser |
Island |
15.4.2021 |
|
EU/1/21/1536 |
Thiotepa Riemser |
Liechtenstein |
30.4.2021 |
|
EU/1/21/1536 |
Thiotepa Riemser |
Norge |
8.4.2021 |
|
EU/1/18/1351 |
Trecondi |
Liechtenstein |
15.1.2021 |
|
EU/1/19/1419 |
Trepulmix |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1498 |
Trixeo Aerosphere |
Island |
8.1.2021 |
|
EU/1/20/1498 |
Trixeo Aerosphere |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1526 |
Tukysa |
Island |
19.2.2021 |
|
EU/1/20/1526 |
Tukysa |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1526 |
Tukysa |
Norge |
25.2.2021 |
|
EU/2/20/257 |
Tulinovet |
Liechtenstein |
15.1.2021 |
|
EU/2/20/252 |
Tulissin |
Liechtenstein |
28.2.2021 |
|
EU/2/21/272 |
Ultifend ND IBD |
Island |
12.5.2021 |
|
EU/2/21/272 |
Ultifend ND IBD |
Liechtenstein |
30.4.2021 |
|
EU/2/21/272 |
Ultifend ND IBD |
Norge |
29.4.2021 |
|
EU/1/20/1524 |
Vazkepa |
Island |
30.3.2021 |
|
EU/1/20/1524 |
Vazkepa |
Liechtenstein |
30.4.2021 |
|
EU/1/20/1524 |
Vazkepa |
Norge |
8.4.2021 |
|
EU/2/20/266 |
Vectormune FP ILT |
Island |
5.1.2021 |
|
EU/2/20/266 |
Vectormune FP ILT |
Liechtenstein |
15.1.2021 |
|
EU/2/20/266 |
Vectormune FP ILT |
Norge |
4.1.2021 |
|
EU/1/18/1298 |
Veyvondi |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1481 |
Vocabria |
Island |
26.1.2021 |
|
EU/1/20/1481 |
Vocabria |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1500 |
Xofluza |
Island |
12.1.2021 |
|
EU/1/20/1500 |
Xofluza |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1500 |
Xofluza |
Norge |
14.1.2021 |
|
EU/1/20/1513 |
Yuflyma |
Island |
24.2.2021 |
|
EU/1/20/1513 |
Yuflyma |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1513 |
Yuflyma |
Norge |
25.2.2021 |
|
EU/2/17/210 |
Zeleris |
Liechtenstein |
28.2.2021 |
|
EU/2/09/186 |
Zulvac 8 Bovis |
Liechtenstein |
28.2.2021 |
|
EU/2/17/207 |
Zulvac BTV Ovis |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1478 |
Zynrelef |
Liechtenstein |
15.1.2021 |
BILAG II
Liste over fornyede markedsføringstilladelser
Følgende markedsføringstilladelser er blevet fornyet i EØS-EFTA-staterne i perioden 1. januar-30. juni 2021:
|
EU-Nummer |
Produkt |
Land |
Udstedelsesdato |
|
EU/1/12/794 |
ADCETRIS |
Liechtenstein |
15.1.2021 |
|
EU/1/16/1098 |
Alprolix |
Island |
25.2.2021 |
|
EU/1/16/1098 |
Alprolix |
Liechtenstein |
30.4.2021 |
|
EU/1/16/1098 |
Alprolix |
Norge |
23.3.2021 |
|
EU/1/16/1092 |
Amlodipine/Valsartan Mylan |
Island |
25.1.2021 |
|
EU/1/16/1092 |
Amlodipine/Valsartan Mylan |
Liechtenstein |
28.2.2021 |
|
EU/1/15/1045 |
Aripiprazole Accord |
Liechtenstein |
15.1.2021 |
|
EU/1/16/1091 |
Atazanavir Mylan |
Island |
17.5.2021 |
|
EU/1/16/1091 |
Atazanavir Mylan |
Liechtenstein |
30.4.2021 |
|
EU/1/16/1091 |
Atazanavir Mylan |
Norge |
3.5.2021 |
|
EU/1/15/1074 |
Benepali |
Liechtenstein |
15.1.2021 |
|
EU/1/20/1474 |
Blenrep |
Liechtenstein |
30.6.2021 |
|
EU/1/16/1114 |
Bortezomib Hospira |
Island |
17.5.2021 |
|
EU/1/16/1114 |
Bortezomib Hospira |
Liechtenstein |
30.6.2021 |
|
EU/1/16/1114 |
Bortezomib Hospira |
Norge |
7.5.2021 |
|
EU/1/16/1102 |
Bortezomib SUN |
Liechtenstein |
30.6.2021 |
|
EU/1/16/1102 |
Bortezomib SUN |
Norge |
30.6.2021 |
|
EU/1/13/818 |
Bosulif |
Island |
22.2.2021 |
|
EU/1/13/818 |
Bosulif |
Norge |
8.3.2021 |
|
EU/1/13/818 |
Bosulif |
Liechtenstein |
28.2.2021 |
|
EU/1/15/1073 |
Briviact |
Liechtenstein |
15.1.2021 |
|
EU/1/16/1136 |
Cabometyx |
Island |
12.5.2021 |
|
EU/1/16/1136 |
Cabometyx |
Liechtenstein |
30.4.2021 |
|
EU/1/16/1136 |
Cabometyx |
Norge |
3.5.2021 |
|
EU/1/11/749 |
Caprelsa |
Island |
15.1.2021 |
|
EU/1/11/749 |
Caprelsa |
Norge |
3.2.2021 |
|
EU/1/11/749 |
Caprelsa |
Liechtenstein |
28.2.2021 |
|
EU/1/15/1055 |
Ciambra |
Liechtenstein |
28.2.2021 |
|
EU/1/15/1054 |
Cinacalcet Mylan |
Liechtenstein |
15.1.2021 |
|
EU/1/16/1125 |
Cinqaero |
Island |
10.6.2021 |
|
EU/1/16/1125 |
Cinqaero |
Liechtenstein |
30.6.2021 |
|
EU/1/16/1125 |
Cinqaero |
Norge |
10.6.2021 |
|
EU/1/16/1087 |
Coagadex |
Island |
14.4.2021 |
|
EU/1/16/1087 |
Coagadex |
Liechtenstein |
30.4.2021 |
|
EU/1/16/1087 |
Coagadex |
Norge |
7.4.2021 |
|
EU/1/13/890 |
Cometriq |
Island |
11.3.2021 |
|
EU/1/13/890 |
Cometriq |
Liechtenstein |
28.2.2021 |
|
EU/1/17/1262 |
Crysvita |
Island |
2.2.2021 |
|
EU/1/17/1262 |
Crysvita |
Liechtenstein |
28.2.2021 |
|
EU/1/17/1262 |
Crysvita |
Norge |
2.2.2021 |
|
EU/1/13/875 |
Deltyba |
Island |
26.4.2021 |
|
EU/1/13/875 |
Deltyba |
Liechtenstein |
30.4.2021 |
|
EU/1/16/1099 |
Descovy |
Island |
10.3.2021 |
|
EU/1/16/1099 |
Descovy |
Liechtenstein |
28.2.2021 |
|
EU/1/16/1099 |
Descovy |
Norge |
15.3.2021 |
|
EU/1/15/1051 |
Ebymect |
Liechtenstein |
28.2.2021 |
|
EU/1/15/1052 |
Edistride |
Liechtenstein |
28.2.2021 |
|
EU/1/11/691 |
Eliquis |
Island |
19.1.2021 |
|
EU/1/11/691 |
Eliquis |
Liechtenstein |
28.2.2021 |
|
EU/1/11/691 |
Eliquis |
Norge |
18.1.2021 |
|
EU/1/15/1046 |
Elocta |
Norge |
22.2.2021 |
|
EU/1/16/1088 |
Empliciti |
Island |
13.1.2021 |
|
EU/1/16/1088 |
Empliciti |
Liechtenstein |
15.1.2021 |
|
EU/1/16/1105 |
EndolucinBeta |
Island |
18.2.2021 |
|
EU/1/16/1105 |
EndolucinBeta |
Liechtenstein |
28.2.2021 |
|
EU/1/16/1105 |
EndolucinBeta |
Norge |
16.2.2021 |
|
EU/1/16/1116 |
Epclusa |
Island |
25.3.2021 |
|
EU/1/16/1116 |
Epclusa |
Liechtenstein |
30.4.2021 |
|
EU/1/16/1116 |
Epclusa |
Norge |
25.3.2021 |
|
EU/1/15/1069 |
Episalvan |
Liechtenstein |
15.1.2021 |
|
EU/1/15/1065 |
Eptifibatid Accord |
Liechtenstein |
15.1.2021 |
|
EU/1/19/1392 |
Ervebo |
Norge |
3.2.2021 |
|
EU/1/19/1392 |
Ervebo-Ebola Zaire-Impfstoff |
Liechtenstein |
15.1.2021 |
|
EU/2/16/194 |
Evalon |
Island |
24.2.2021 |
|
EU/2/16/194 |
Evalon |
Liechtenstein |
28.2.2021 |
|
EU/2/16/194 |
Evalon |
Norge |
26.2.2021 |
|
EU/1/15/1075 |
Feraccru |
Liechtenstein |
15.1.2021 |
|
EU/1/16/1106 |
Flixabi |
Island |
10.3.2021 |
|
EU/1/16/1106 |
Flixabi |
Liechtenstein |
30.4.2021 |
|
EU/1/16/1106 |
Flixabi |
Norge |
7.4.2021 |
|
EU/1/15/1082 |
Galafold |
Island |
25.2.2021 |
|
EU/1/15/1082 |
Galafold |
Liechtenstein |
28.2.2021 |
|
EU/1/15/1082 |
Galafold |
Norge |
23.2.2021 |
|
EU/1/15/1061 |
Genvoya |
Liechtenstein |
28.2.2021 |
|
EU/1/11/677 |
Gilenya |
Liechtenstein |
15.1.2021 |
|
EU/1/15/1008 |
Hetlioz |
Liechtenstein |
28.2.2021 |
|
EU/1/14/987 |
Holoclar |
Island |
25.1.2021 |
|
EU/1/14/987 |
Holoclar |
Liechtenstein |
28.2.2021 |
|
EU/1/16/1095 |
Idelvion |
Island |
18.2.2021 |
|
EU/1/16/1095 |
Idelvion |
Liechtenstein |
28.2.2021 |
|
EU/1/16/1095 |
Idelvion |
Norge |
11.2.2021 |
|
EU/1/15/1064 |
Imlygic |
Liechtenstein |
15.1.2021 |
|
EU/2/15/193 |
Imrestor |
Liechtenstein |
15.1.2021 |
|
EU/1/11/676 |
Jevtana |
Island |
8.1.2021 |
|
EU/1/11/676 |
Jevtana |
Liechtenstein |
15.1.2021 |
|
EU/1/16/1128 |
Kisplyx |
Liechtenstein |
30.6.2021 |
|
EU/1/16/1128 |
Kisplyx |
Norge |
22.6.2021 |
|
EU/1/15/1076 |
Kovaltry |
Liechtenstein |
15.1.2021 |
|
EU/2/16/195 |
Letifend |
Island |
24.2.2021 |
|
EU/2/16/195 |
Letifend |
Liechtenstein |
28.2.2021 |
|
EU/2/16/195 |
Letifend |
Norge |
5.3.2021 |
|
EU/1/19/1376 |
Libtayo |
Liechtenstein |
30.6.2021 |
|
EU/1/19/1376 |
Libtayo |
Island |
21.5.2021 |
|
EU/1/19/1376 |
Libtayo |
Norge |
21.5.2021 |
|
EU/1/16/1096 |
Lonsurf |
Island |
8.1.2021 |
|
EU/1/16/1096 |
Lonsurf |
Liechtenstein |
15.1.2021 |
|
EU/1/16/1096 |
Lonsurf |
Norge |
8.1.2021 |
|
EU/1/15/1067 |
Lopinavir/Ritonavir Mylan |
Liechtenstein |
15.1.2021 |
|
EU/1/19/1355 |
Lorviqua |
Island |
26.4.2021 |
|
EU/1/19/1355 |
Lorviqua |
Liechtenstein |
30.4.2021 |
|
EU/1/19/1355 |
Lorviqua |
Norge |
8.4.2021 |
|
EU/1/15/1078 |
Natpar |
Island |
27.4.2021 |
|
EU/1/15/1078 |
Natpar |
Liechtenstein |
30.4.2021 |
|
EU/1/15/1078 |
Natpar |
Norge |
26.4.2021 |
|
EU/1/15/1053 |
Neofordex |
Island |
15.1.2021 |
|
EU/1/15/1053 |
Neofordex |
Liechtenstein |
15.1.2021 |
|
EU/1/15/1053 |
Neofordex |
Norge |
31.1.2021 |
|
EU/1/16/1103 |
Neparvis |
Island |
22.2.2021 |
|
EU/1/16/1103 |
Neparvis |
Liechtenstein |
28.2.2021 |
|
EU/1/16/1103 |
Neparvis |
Norge |
16.2.2021 |
|
EU/1/16/1094 |
Ninlaro |
Liechtenstein |
15.1.2021 |
|
EU/1/16/1094 |
Ninlaro |
Norge |
22.2.2021 |
|
EU/1/16/1124 |
Nordimet |
Liechtenstein |
30.6.2021 |
|
EU/1/16/1124 |
Nordimet |
Norge |
25.6.2021 |
|
EU/1/15/1035 |
Obizur |
Liechtenstein |
28.2.2021 |
|
EU/1/16/1139 |
Ocaliva |
Island |
25.1.2021 |
|
EU/1/16/1139 |
Ocaliva |
Norge |
3.2.2021 |
|
EU/1/16/1139 |
Ocaliva |
Liechtenstein |
28.2.2021 |
|
EU/1/16/1112 |
Odefsey |
Island |
19.1.2021 |
|
EU/1/16/1112 |
Odefsey |
Liechtenstein |
28.2.2021 |
|
EU/1/16/1112 |
Odefsey |
Norge |
14.1.2021 |
|
EU/1/15/1070 |
Oncaspar |
Liechtenstein |
15.1.2021 |
|
EU/1/18/1345 |
Ondexxya |
Island |
2.3.2021 |
|
EU/1/18/1345 |
Ondexxya |
Liechtenstein |
28.2.2021 |
|
EU/1/18/1345 |
Ondexxya |
Norge |
8.3.2021 |
|
EU/1/15/1066 |
Ongentys |
Island |
15.3.2021 |
|
EU/1/15/1066 |
Ongentys |
Liechtenstein |
28.2.2021 |
|
EU/1/15/1066 |
Ongentys |
Norge |
15.3.2021 |
|
EU/1/15/1059 |
Orkambi |
Liechtenstein |
15.1.2021 |
|
EU/1/16/1104 |
Palonosetron Accord |
Island |
22.2.2021 |
|
EU/1/16/1104 |
Palonosetron Accord |
Liechtenstein |
28.2.2021 |
|
EU/1/16/1104 |
Palonosetron Accord |
Norge |
26.2.2021 |
|
EU/1/16/1089 |
Pandemic influenza vaccine H5N1 AstraZeneca |
Island |
16.3.2021 |
|
EU/1/16/1089 |
Pandemic influenza vaccine H5N1 AstraZeneca |
Liechtenstein |
30.4.2021 |
|
EU/1/16/1089 |
Pandemic influenza vaccine H5N1 AstraZeneca |
Norge |
24.3.2021 |
|
EU/1/15/1071 |
Pemetrexed Accord |
Liechtenstein |
28.2.2021 |
|
EU/1/16/1115 |
Pemetrexed Fresenius Kabi |
Island |
12.5.2021 |
|
EU/1/16/1115 |
Pemetrexed Fresenius Kabi |
Liechtenstein |
30.4.2021 |
|
EU/1/16/1115 |
Pemetrexed Fresenius Kabi |
Norge |
20.5.2021 |
|
EU/1/15/1057 |
Pemetrexed Hospira |
Liechtenstein |
28.2.2021 |
|
EU/1/19/1388 |
Polivy |
Island |
5.1.2021 |
|
EU/1/19/1388 |
Polivy |
Liechtenstein |
15.1.2021 |
|
EU/1/16/1108 |
Qtern |
Island |
9.6.2021 |
|
EU/1/16/1108 |
Qtern |
Liechtenstein |
30.4.2021 |
|
EU/1/16/1108 |
Qtern |
Norge |
3.6.2021 |
|
EU/1/16/1090 |
Rasagiline Mylan |
Liechtenstein |
15.1.2021 |
|
EU/1/20/1460 |
Rozlytrek |
Liechtenstein |
30.6.2021 |
|
EU/1/17/1250 |
Rubraca |
Island |
15.3.2021 |
|
EU/1/17/1250 |
Rubraca |
Liechtenstein |
30.4.2021 |
|
EU/1/17/1250 |
Rubraca |
Norge |
11.3.2021 |
|
EU/2/16/196 |
Sevohale |
Island |
14.5.2021 |
|
EU/2/16/196 |
Sevohale |
Liechtenstein |
30.4.2021 |
|
EU/2/16/196 |
Sevohale |
Norge |
7.5.2021 |
|
EU/1/16/1135 |
Sialanar |
Liechtenstein |
30.6.2021 |
|
EU/1/16/1135 |
Sialanar |
Norge |
30.6.2021 |
|
EU/1/13/901 |
Sirturo |
Island |
14.1.2021 |
|
EU/1/13/901 |
Sirturo |
Liechtenstein |
28.2.2021 |
|
EU/1/13/901 |
Sirturo |
Norge |
8.2.2021 |
|
EU/1/15/1072 |
Spectrila |
Liechtenstein |
15.1.2021 |
|
EU/1/16/1097 |
Strimvelis |
Island |
14.5.2021 |
|
EU/1/16/1097 |
Strimvelis |
Liechtenstein |
30.6.2021 |
|
EU/1/16/1097 |
Strimvelis |
Norge |
7.5.2021 |
|
EU/1/15/1085 |
Taltz |
Island |
29.1.2021 |
|
EU/1/15/1085 |
Taltz |
Liechtenstein |
15.1.2021 |
|
EU/1/15/1085 |
Taltz |
Norge |
14.1.2021 |
|
EU/1/13/902 |
Translarna |
Liechtenstein |
28.2.2021 |
|
EU/1/15/1083 |
Uptravi |
Island |
8.1.2021 |
|
EU/1/15/1083 |
Uptravi |
Liechtenstein |
15.1.2021 |
|
EU/1/15/1079 |
Vaxelis |
Liechtenstein |
15.1.2021 |
|
EU/2/15/188 |
Vectormune ND |
Island |
18.2.2021 |
|
EU/2/15/188 |
Vectormune ND |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1459 |
Veklury |
Liechtenstein |
30.6.2021 |
|
EU/1/15/1068 |
Wakix |
Island |
29.1.2021 |
|
EU/1/15/1068 |
Wakix |
Liechtenstein |
28.2.2021 |
|
EU/1/19/1360 |
Waylivra |
Island |
18.2.2021 |
|
EU/1/19/1360 |
Waylivra |
Norge |
1.3.2021 |
|
EU/1/19/1360 |
Waylivra |
Liechtenstein |
28.2.2021 |
|
EU/1/15/1042 |
Zalviso |
Liechtenstein |
15.1.2021 |
|
EU/1/16/1109 |
Zavicefta |
Island |
24.2.2021 |
|
EU/1/16/1109 |
Zavicefta |
Liechtenstein |
28.2.2021 |
|
EU/1/16/1109 |
Zavicefta |
Norge |
26.2.2021 |
|
EU/1/16/1119 |
Zepatier |
Island |
14.5.2021 |
|
EU/1/16/1119 |
Zepatier |
Liechtenstein |
30.6.2021 |
|
EU/1/16/1119 |
Zepatier |
Norge |
18.5.2021 |
|
EU/1/11/690 |
Zoely |
Island |
25.5.2021 |
|
EU/1/11/690 |
Zoely |
Liechtenstein |
30.6.2021 |
|
EU/1/11/690 |
Zoely |
Norge |
31.5.2021 |
|
EU/1/20/1443 |
Zolgensma |
Island |
8.6.2021 |
|
EU/1/20/1443 |
Zolgensma |
Liechtenstein |
30.6.2021 |
|
EU/1/20/1443 |
Zolgensma |
Norge |
2.6.2021 |
|
EU/1/16/1093 |
Zonisamide Mylan |
Island |
4.1.2021 |
|
EU/1/16/1093 |
Zonisamide Mylan |
Liechtenstein |
28.2.2021 |
BILAG III
Liste over udvidede markedsføringstilladelser
Følgende markedsføringstilladelser er blevet udstedt i EØS-EFTA-staterne i perioden 1. januar-30. juni 2021:
|
EU-Nummer |
Produkt |
Land |
Udstedelsesdato |
|
EU/1/13/838/006 |
Aubagio |
Norge |
22.6.2021 |
|
EU/1/18/1336/009 |
Buvidal |
Island |
16.6.2021 |
|
EU/1/18/1336/009 |
Buvidal |
Norge |
3.6.2021 |
|
EU/1/06/367/013 |
Diacomit |
Island |
10.6.2021 |
|
EU/1/06/367/013 |
Diacomit |
Norge |
10.6.2021 |
|
EU/2/11/128/004-010 |
Emdocam |
Island |
25.5.2021 |
|
EU/1/18/1319/009-010 |
Hulio |
Island |
18.1.2021 |
|
EU/1/18/1319/009-010 |
Hulio |
Norge |
18.1.2021 |
|
EU/1/20/1447/006-007 |
Insulin Aspart Sanofi |
Island |
14.5.2021 |
|
EU/1/20/1447/006-007 |
Insulin Aspart Sanofi |
Norge |
4.5.2021 |
|
EU/1/19/1364/002 |
Nuceiva |
Island |
29.1.2021 |
|
EU/1/19/1364/002 |
Nuceiva |
Norge |
27.1.2021 |
|
EU/1/14/934/007-008 |
Plegridy |
Island |
8.1.2021 |
|
EU/1/08/442/025-031 |
Pradaxa |
Island |
21.1.2021 |
|
EU/1/08/442/025-031 |
Pradaxa |
Norge |
19.1.2021 |
|
EU/1/13/901/003 |
Sirturo |
Island |
15.4.2021 |
|
EU/1/13/901/003 |
Sirturo |
Norge |
8.4.2021 |
|
EU/1/19/1361/002-003 |
Skyrizi |
Island |
10.6.2021 |
|
EU/1/19/1361/002-003 |
Skyrizi |
Norge |
4.6.2021 |
|
EU/1/10/622/003 |
Tepadina |
Island |
15.4.2021 |
|
EU/1/10/622/003 |
Tepadina |
Norge |
19.4.2021 |
|
EU/1/13/892/007 |
Tivicay |
Island |
25.1.2021 |
|
EU/1/13/892/007 |
Tivicay |
Norge |
18.1.2021 |
|
EU/1/17/1208/006-009 |
Trimbow |
Island |
29.1.2021 |
|
EU/1/17/1208/010-012 |
Trimbow |
Island |
26.4.2021 |
|
EU/1/17/1208/006-009 |
Trimbow |
Norge |
26.1.2021 |
|
EU/1/17/1208/010-012 |
Trimbow |
Norge |
12.4.2021 |
|
EU/1/06/346/002 |
Tysabri |
Island |
15.4.2021 |
|
EU/1/06/346/002 |
Tysabri |
Norge |
8.4.2021 |
|
EU/1/08/472/050-051 |
Xarelto |
Island |
1.2.2021 |
|
EU/1/17/472/050-051 |
Xarelto |
Norge |
26.1.2021 |
|
EU/1/18/1312/003-004 |
Xerava |
Island |
2.3.2021 |
|
EU/1/18/1312/003-004 |
Xerava |
Norge |
5.3.2021 |
BILAG IV
Liste over tilbagetrukne markedsføringstilladelser
Følgende markedsføringstilladelser er blevet trukket tilbage i EØS-EFTA-staterne i perioden 1. januar-30. juni 2021:
|
EU-Nummer |
Produkt |
Land |
Dato for tilbagetrækning |
|
EU/2/08/088 |
Acticam |
Island |
26.3.2021 |
|
EU/2/08/088 |
Acticam |
Liechtenstein |
30.4.2021 |
|
EU/2/08/088 |
Acticam |
Norge |
26.3.2021 |
|
EU/1/16/1122 |
Aerivio Spiromax |
Liechtenstein |
28.2.2021 |
|
EU/1/16/1123 |
Airexar Spiromax |
Liechtenstein |
28.2.2021 |
|
EU/1/18/1269 |
Alpivab |
Liechtenstein |
15.1.2021 |
|
EU/1/07/390 |
Altargo |
Liechtenstein |
28.2.2021 |
|
EU/1/10/625 |
Arzerra |
Liechtenstein |
28.2.2021 |
|
EU/1/06/355 |
ATryn |
Liechtenstein |
28.2.2021 |
|
EU/1/19/1382 |
Azacitidin Celgene |
Liechtenstein |
30.6.2021 |
|
EU/1/19/1382 |
Azacitidine Celgene |
Island |
25.5.2021 |
|
EU/1/19/1382 |
Azacitidine Celgene |
Norge |
16.6.2021 |
|
EU/1/15/1081 |
Caspofungin Accord |
Island |
25.2.2021 |
|
EU/1/15/1081 |
Caspofungin Accord |
Liechtenstein |
28.2.2021 |
|
EU/1/10/623 |
Clopidogrel/Acetylsalicylic acid Zentiva |
Liechtenstein |
28.2.2021 |
|
EU/1/10/623 |
Clopidogrel/Acetylsalicylic acid Zentiva |
Norge |
1.3.2021 |
|
EU/1/96/024 |
Crixivan |
Island |
14.4.2021 |
|
EU/1/96/024 |
Crixivan |
Liechtenstein |
30.4.2021 |
|
EU/1/96/024 |
Crixivan |
Norge |
16.6.2021 |
|
EU/1/17/1240 |
Cyltezo |
Liechtenstein |
28.2.2021 |
|
EU/1/01/187 |
DepoCyte |
Liechtenstein |
28.2.2021 |
|
EU/1/18/1300 |
Duzallo |
Liechtenstein |
28.2.2021 |
|
EU/1/13/908 |
Eperzan |
Liechtenstein |
28.2.2021 |
|
EU/1/09/510 |
Fertavid |
Liechtenstein |
28.2.2021 |
|
EU/1/18/1288 |
Halimatoz |
Island |
12.1.2021 |
|
EU/1/18/1288 |
Halimatoz |
Liechtenstein |
28.2.2021 |
|
EU/1/18/1288 |
Halimatoz |
Norge |
9.2.2021 |
|
EU/1/00/144 |
Helixate NexGen |
Liechtenstein |
28.2.2021 |
|
EU/1/13/876 |
Imatinib Medac |
Liechtenstein |
28.2.2021 |
|
EU/1/17/1243 |
Imatinib Teva B.V. |
Liechtenstein |
28.2.2021 |
|
EU/1/08/505 |
Intanza |
Liechtenstein |
28.2.2021 |
|
EU/1/01/191 |
Ketek |
Liechtenstein |
28.2.2021 |
|
EU/1/13/895 |
Kolbam |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1516 |
Lextemy |
Liechtenstein |
30.6.2021 |
|
EU/1/16/1162 |
Lusduna |
Liechtenstein |
28.2.2021 |
|
EU/1/05/325 |
Macugen |
Liechtenstein |
28.2.2021 |
|
EU/1/04/297 |
Nodetrip (tidl.Xeristar) |
Liechtenstein |
30.6.2021 |
|
EU/1/04/297 |
Nodetrip (tidl.Xeristar) |
Norge |
16.6.2021 |
|
EU/1/01/186 |
Nonafact |
Liechtenstein |
28.2.2021 |
|
EU/1/15/1044 |
Numient |
Liechtenstein |
28.2.2021 |
|
EU/1/14/924 |
Olysio |
Liechtenstein |
28.2.2021 |
|
EU/1/04/287 |
Osseor |
Liechtenstein |
28.2.2021 |
|
EU/1/00/131 |
PegIntron |
Island |
17.5.2021 |
|
EU/1/00/131 |
PegIntron |
Liechtenstein |
30.4.2021 |
|
EU/1/00/131 |
PegIntron |
Norge |
6.5.2021 |
|
EU/1/15/1084 |
Portrazza |
Island |
2.3.2021 |
|
EU/1/15/1084 |
Portrazza |
Liechtenstein |
28.2.2021 |
|
EU/1/08/453 |
Prepandrix |
Island |
14.1.2021 |
|
EU/1/08/453 |
Prepandrix |
Liechtenstein |
28.2.2021 |
|
EU/1/08/453 |
Prepandrix |
Norge |
9.2.2021 |
|
EU/1/04/288 |
Protelos |
Liechtenstein |
28.2.2021 |
|
EU/1/20/1463 |
Qutavina |
Liechtenstein |
15.1.2021 |
|
EU/1/10/634 |
Ribavirin Mylan |
Liechtenstein |
28.2.2021 |
|
EU/1/07/388 |
Sebivo |
Liechtenstein |
15.1.2021 |
|
EU/1/06/358 |
Silgard |
Liechtenstein |
28.2.2021 |
|
EU/1/16/1163 |
Solymbic |
Liechtenstein |
28.2.2021 |
|
EU/1/15/1017 |
Taxespira |
Liechtenstein |
28.2.2021 |
|
EU/1/09/610 |
Telmisartan Teva |
Island |
9.6.2021 |
|
EU/1/09/610 |
Telmisartan Teva |
Liechtenstein |
30.6.2021 |
|
EU/1/09/610 |
Telmisartan Teva |
Norge |
16.6.2021 |
|
EU/1/09/552 |
Topotecan Teva |
Liechtenstein |
28.2.2021 |
|
EU/1/16/1126 |
Truberzi |
Island |
12.1.2021 |
|
EU/1/16/1126 |
Truberzi |
Liechtenstein |
15.1.2021 |
|
EU/1/16/1126 |
Truberzi |
Norge |
3.2.2021 |
|
EU/1/18/1303 |
Udenyca |
Island |
18.2.2021 |
|
EU/1/18/1303 |
Udenyca |
Liechtenstein |
28.2.2021 |
|
EU/1/18/1303 |
Udenyca |
Norge |
15.2.2021 |
|
EU/1/17/1180 |
Varuby |
Liechtenstein |
28.2.2021 |
|
EU/1/12/752 |
Vepacel |
Liechtenstein |
15.1.2021 |
|
EU/1/11/705 |
Vibativ |
Liechtenstein |
28.2.2021 |
|
EU/1/11/704 |
Victrelis |
Liechtenstein |
28.2.2021 |
|
EU/1/00/132 |
ViraferonPeg |
Island |
19.1.2021 |
|
EU/1/00/132 |
ViraferonPeg |
Liechtenstein |
28.2.2021 |
|
EU/1/00/132 |
ViraferonPeg |
Norge |
29.1.2021 |
|
EU/1/11/671 |
Xiapex |
Liechtenstein |
28.2.2021 |
|
EU/1/16/1121 |
Zalmoxis |
Liechtenstein |
28.2.2021 |
BILAG V
Liste over suspenderede markedsføringstilladelser
Følgende markedsføringstilladelser er blevet suspenderet i EØS-EFTA-staterne i perioden 1. januar-30. juni 2021:
|
EU-Nummer |
Produkt |
Land |
Suspensionsdato |